Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04510103Completed
Randomised, double-blind trial in xerosis cutis (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Clinical Grading of Skin Dryness at 6 weeks. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04510103.